MINI FUTURE LONG - SMITH & NEPHEW | Market Closed - Börse Stuttgart 03:49:33 17/05/2024 pm IST | ||
| 3.11 EUR | +1.97% |
|
| Current month | +21.01% | ||
| 1 month | +32.34% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
Latest news about SMITH & NEPHEW PLC
More news
| Date | Price | Change |
|---|---|---|
| 17/24/17 | 3.11 | +1.97% |
| 16/24/16 | 3.05 | -0.65% |
| 15/24/15 | 3.07 | -1.60% |
| 14/24/14 | 3.12 | +7.96% |
| 13/24/13 | 2.89 | -1.03% |
Delayed Quote Börse Stuttgart
Last update May 17, 2024 at 03:49 pm IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Morgan Stanley |
| WKN | ME4AZ8 |
| ISIN | DE000ME4AZ80 |
| Date issued | 29/11/2023 |
| Strike | 756.9 p |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 3.21 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.53 € |
|---|---|
| Lowest since issue | 2.35 € |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
13
USD
Average target price
16.35
USD
Spread / Average Target
+25.69%
- Stock Market
- Certificates
- Certificat
